Acute cardiovascular events after discontinuation of xanthine oxidase inhibitors: a cohort study - Top-Institutions - MDSpire

Acute cardiovascular events after discontinuation of xanthine oxidase inhibitors: a cohort study

  • By

  • Joseph Magagnoli

  • Tammy H. Cummings

  • Meenakshi Ambati

  • S. Scott Sutton

  • Jayakrishna Ambati

  • December 26, 2025

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Cardiology
    • Rheumatology
    • Clinical Pharmacology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Cardiology
    • Rheumatology
    • Epidemiology

  • #3

    Brigham and Women’s Hospital
    Brigham and Women’s Hospital

    Boston, MA

    Key Differentiators

    • Cardiology
    • Rheumatology
    • Pharmacoepidemiology

  • #4

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Rheumatology
    • Clinical Epidemiology

  • #5

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Cardiology
    • Rheumatology
    • Pharmacoepidemiology

Original Source(s)

Acute cardiovascular events after discontinuation of xanthine oxidase inhibitors: a cohort study

  • by Joseph Magagnoli, Tammy H. Cummings, Meenakshi Ambati, S. Scott Sutton, Jayakrishna Ambati

  • December 26, 2025

Related Content

Gout May Signal Higher Stroke Risk in AF

In a nationwide Finnish cohort, patients with atrial fibrillation and gout had higher ischemic stroke rates, while urate-lowering therapy was associated with lower stroke rates.

Individuals with Hyperuricemia Tend to Use More Analgesics Compared to Those with Normal Uric Acid Levels—Is Asymptomatic Hyperuricemia Truly Without Symptoms?

NPs Top US Jobs List Again

The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.